NCT06933251 2026-03-09
PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer
Guangdong Provincial People's Hospital
Phase 2 Active not recruiting
Clinical Trials
11 trialsNCT06459869 2026-02-17
FORTRESS
Akamis Bio
Phase 1 Recruiting
NCT07381777 2026-02-02
IMMUNOSTAR
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2 Not yet recruiting
NCT06688786 2026-01-27
FIRM
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Active not recruiting
NCT07351708 2026-01-20
PROMISE model
Sixth Affiliated Hospital, Sun Yat-sen University
Completed
NCT06864013 2026-01-14
SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT07269249 2025-12-08
RW-NEDOS
National Cancer Institute, Naples
Recruiting
NCT07040098 2025-06-26
STELLARIII
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT07020247 2025-06-13
Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study
West China Hospital
Phase 3 Recruiting
NCT06761287 2025-05-30
OPAL
Centre Hospitalier Universitaire Saint Pierre
Phase NA Recruiting
NCT06653452 2024-10-22
Application of PET/MRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Peking Union Medical College Hospital
Phase NA Recruiting